Omeros (OMER) Cash from Operations (2010 - 2026)
Omeros (OMER) reported Cash from Operations of 14506000.0 for Q1 2026, up 59.53% on a YoY basis from 9093143.03 in Q1 2025, and up 63.59% sequentially from 39842000.0 in Q4 2025.
Omeros (OMER) Cash from Operations (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Cash from Operations data on file, last reported at 14506000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 59.53% year-over-year to 14506000.0; the trailing twelve-month figure through Mar 2026 stood at 94759000.0 (up 33.67% YoY), and the FY2025 full-year result was 116094000.0, up 21.98% from the prior year.
- Cash from Operations climbed to 14506000.0 in Q1 2026, from 39842000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 174539000.0 in Q1 2023 to a low of 45985000.0 in Q2 2024.
- A 5-year average of 17127058.82 and a median of 28980000.0 in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations jumped 1248.81% in 2023 and sank 123.94% in 2024, its largest moves.
- Tracing OMER's Cash from Operations over 5 years: stood at 25382000.0 in 2022, then slumped by 37.2% to 34825000.0 in 2023, then rose by 16.78% to 28980000.0 in 2024, then sank by 37.48% to 39842000.0 in 2025, then surged by 63.59% to 14506000.0 in 2026.
- Business Quant data shows OMER's Cash from Operations at 14506000.0 in Q1 2026, 39842000.0 in Q4 2025, and 18473000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | -14.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.51 Mn |
| Mar 31, 2026 | -14.51 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Dec 31, 2025 | -39.84 Mn |
| Sep 30, 2025 | -18.47 Mn |
| Sep 30, 2025 | -18.47 Mn |
| Jun 30, 2025 | -21.94 Mn |
| Jun 30, 2025 | -21.94 Mn |
| Mar 31, 2025 | -35.84 Mn |
| Mar 31, 2025 | -35.84 Mn |
| Dec 31, 2024 | -28.98 Mn |
| Dec 31, 2024 | -28.98 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Sep 30, 2024 | -32.06 Mn |
| Jun 30, 2024 | -45.99 Mn |
| Jun 30, 2024 | -45.99 Mn |
| Mar 31, 2024 | -41.78 Mn |
| Mar 31, 2024 | -41.78 Mn |
| Dec 31, 2023 | -34.83 Mn |
| Dec 31, 2023 | -34.83 Mn |